These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3501578)

  • 1. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
    Mele A; Cabib S; Oliverio A; Melchiorri P; Puglisi-Allegra S
    Peptides; 1987; 8(5):935-8. PubMed ID: 3501578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake.
    Gosnell BA; Morley JE; Levine AS
    Pharmacol Biochem Behav; 1983 Nov; 19(5):771-5. PubMed ID: 6359178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sauvagine: effects on thermoregulation in the rat.
    Broccardo M
    Pharmacol Res; 1990; 22(2):189-96. PubMed ID: 2330343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM; Corder R
    Br J Pharmacol; 1999 Jan; 126(1):317-25. PubMed ID: 10051151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the thermogenic effects of CRF, sauvagine and urotensin I in the rat.
    Le Feuvre RA; Rothwell NJ; White A
    Horm Metab Res; 1989 Sep; 21(9):525-6. PubMed ID: 2583676
    [No Abstract]   [Full Text] [Related]  

  • 7. CRF-like effects of sauvagine and urotensin I on synaptosomal tyrosine hydroxylase activity of mouse striatum.
    Onali P; Olianas MC
    Brain Res; 1990 Sep; 526(2):181-5. PubMed ID: 1979515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intracerebroventricular infusions of CRF, sauvagine, ACTH (1-24) and ACTH (4-10) on blood pressure in sheep.
    Scoggins BA; Coghlan JP; Denton DA; Nelson MA; Lambert PF; Parkes DG; Tregear GW; Tresham JJ; Wang XM
    J Hypertens Suppl; 1984 Dec; 2(3):S67-8. PubMed ID: 6100757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
    Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats.
    Broccardo M; Improta G
    Eur J Pharmacol; 1990 Jul; 182(2):357-62. PubMed ID: 2397746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
    MacCannell KL; Lederis K; Hamilton PL; Rivier J
    Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
    Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
    Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
    Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells.
    Fazal N; Slominski A; Choudhry MA; Wei ET; Sayeed MM
    FEBS Lett; 1998 Sep; 435(2-3):187-90. PubMed ID: 9762905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
    Dunn AJ; Antoon M; Chapman Y
    Brain Res Bull; 1991 Apr; 26(4):539-42. PubMed ID: 1868353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
    Rivier C; Rivier J; Lederis K; Vale W
    Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
    Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sauvagine, urotensin I and CRF on food intake in rats.
    Negri L; Noviello L; Noviello V
    Peptides; 1985; 6 Suppl 3():53-7. PubMed ID: 3879535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the behavioral effects of CRF, sauvagine and urotensin I.
    Britton DR; Hoffman DK; Lederis K; Rivier J
    Brain Res; 1984 Jun; 304(2):201-5. PubMed ID: 6611193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.